Immunomedics is a biopharmaceutical company that specializes in the development and marketing of monoclonal, antibody-based products for cancer, autoimmune, and other serious diseases. The company operates primarily in the United States and Europe, and focuses on research, development, and manufacture of innovative therapies. With a strong commitment to meeting unmet medical needs, Immunomedics is dedicated to improving patient outcomes and advancing the field of biopharmaceuticals.